Inspire Medical Systems (INSP) Tops Q2 EPS by 22c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus

Go back to Inspire Medical Systems (INSP) Tops Q2 EPS by 22c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus

Inspire Medical Systems (INSP) PT Raised to $50 at Oppenheimer

August 5, 2020 7:08 AM EDT

Oppenheimer analyst Suraj Kalia raised the price target on Inspire Medical Systems (NYSE: INSP) to $50.00 (from $42.00) while maintaining a Underperform rating.

The analyst commented, "Inspire reported 2Q revenues/GAAP EPS of $12.2M/($0.88), behind our estimates of $14.1M/($0.79), but ahead of consensus of $7.9M/($1.07)E,... More